Nifedipine-tocolysis-associated atrial fibrillation responds to DC cardioversion [5]

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 2, 2007, Pages 236-237

  Ugwumadu, A ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE;

CARDIOVERSION; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HUMAN; LETTER; MORBIDITY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TOCOLYSIS; VASODILATATION;

ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; NIFEDIPINE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 33846140549     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.01194.x     Document Type: Letter

References (4)

1. Parasuraman R, Gandhi MM, Liversedge NH. Nifedipine tocolysis associated atrial fibrillation responds to DC cardioversion. BJOG 2006;113:844-5.
2. Bakketeig LS, Bjerkedal T, Hoffman HJ. Small-for-gestational age births in successive pregnancy outcomes: results from a longitudinal study of births in Norway. Early Hum Dev 1986;14:187-200.
3. Singh NB. The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol 1986;21:109-21.
4. Sorkin EM, Clissold SP, Brogden RN. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders Drugs 1985;30:182-274.